A randomized, triple-blinded, placebo-controlled clinical trial evaluating immune responses of Typhim Vi and PPSV23 vaccines in healthy adults: The PREP study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized, triple-blinded, placebo-controlled clinical trial evaluating immune responses of Typhim Vi and PPSV23 vaccines in healthy adults: The PREP study

Published:2024-12 Issue:26 Volume:42 Page:126292
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Wang Chunxue,Damiano Robert J.,Ruebush Laura E.,Engelen Mariёlle P.K.J.,Mariani Sara,Liu Luoluo,Silva Ikaro,Borhani Soheil,Cote Gerard L.,Conroy Bryan,McFarlane Daniel,Deutz Nicolaas E.P.

Funder

Defense Threat Reduction Agency

Publisher

Elsevier BV

Reference50 articles.

1. The COVID-19 pandemic and the $16 trillion virus;Cutler;JAMA,2020

2. The challenge of emerging and re-emerging infectious diseases;Morens;Nature,2004

3. Real-time infection prediction with wearable physiological monitoring and AI to aid military workforce readiness during COVID-19;Conroy;Sci Rep,2022

4. Wearable sensor data and self-reported symptoms for COVID-19 detection;Quer;Nat Med,2021

5. Overview of immune response during SARS-CoV-2 infection: lessons from the past;Shah;Front Immunol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP